Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Plos One|April 27, 2026
Community health worker intervention to reduce worker exposure to volatile organic compounds in small business auto and beauty shops in a marginalized community: A cluster randomized controlled trialShannon L Gutenkunst, Nathan Lothrop, Carolina Quijada, et al.
Frontiers in Genetics|August 7, 2025
The peruvian genome project: expanding the global pool of genome diversity from South AmericaHeinner Guio, Cesar Sanchez, Victor Borda, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 30, 2019
Renin-Angiotensin System Blockade and Risk of Heart Failure After Myocardial Infarction Based on Left Ventricular Ejection Fraction: A Retrospective Cohort StudyMaría Cespón-Fernández, Sergio Raposeiras-Roubín, Emad Abu-Assi, et al.
Minerva Cardiology and Angiology|June 17, 2021
Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI RegistrySara Al Raisi, Majd Protty, Sergio Raposeiras-Roubín, et al.
European Heart Journal. Acute Cardiovascular Care|October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMIFederico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)|June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or PrasugrelSergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology|March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registryFabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
Pageof 8